BRPI0414564A - derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia - Google Patents

derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia

Info

Publication number
BRPI0414564A
BRPI0414564A BRPI0414564-0A BRPI0414564A BRPI0414564A BR PI0414564 A BRPI0414564 A BR PI0414564A BR PI0414564 A BRPI0414564 A BR PI0414564A BR PI0414564 A BRPI0414564 A BR PI0414564A
Authority
BR
Brazil
Prior art keywords
sarcopenia
weakness
vitamin
alkylidene
derivatives
Prior art date
Application number
BRPI0414564-0A
Other languages
English (en)
Inventor
Andrew George Lee
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0414564A publication Critical patent/BRPI0414564A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE 2-ALCILIDENO-19-NOR-VITAMINA D PARA O TRATAMENTO DE FRAQUEZA, LESãO MUSCULAR OU SARCOPENIA". A presente invenção refere-se a métodos de tratar fraqueza, lesão muscular ou sarcopenia, os métodos compreendendo administrar a um paciente em sua necessidade um derivado de 2-alcilideno-19-nor-vitamina D. Particularmente, a presente invenção refere-se a métodos de tratar fraqueza, lesão muscular ou sarcopenia, os métodos compreendendo administrar a um paciente em sua necessidade uma quantidade terapeuticamente eficaz de 2-metileno-19-nor-20(S)-1<244>,25-dihidroxivitamina D~ 3~.
BRPI0414564-0A 2003-09-19 2004-09-06 derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia BRPI0414564A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50450903P 2003-09-19 2003-09-19
PCT/IB2004/002901 WO2005027914A1 (en) 2003-09-19 2004-09-06 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia

Publications (1)

Publication Number Publication Date
BRPI0414564A true BRPI0414564A (pt) 2006-11-07

Family

ID=34375511

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414564-0A BRPI0414564A (pt) 2003-09-19 2004-09-06 derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia

Country Status (16)

Country Link
US (1) US20050065129A1 (pt)
EP (1) EP1667688A1 (pt)
JP (1) JP2007505882A (pt)
KR (1) KR20060040744A (pt)
CN (1) CN1852718A (pt)
AU (1) AU2004273659A1 (pt)
BR (1) BRPI0414564A (pt)
CA (1) CA2538993A1 (pt)
IL (1) IL174043A0 (pt)
MX (1) MXPA06002947A (pt)
NO (1) NO20061704L (pt)
NZ (1) NZ545632A (pt)
RU (1) RU2326674C2 (pt)
TW (1) TW200512183A (pt)
WO (1) WO2005027914A1 (pt)
ZA (1) ZA200601721B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014004647A1 (en) * 2012-06-26 2014-01-03 Entia Biosciences, Inc. A nutritional approach to improving athletic performance and reducing injury with l-ergothioneine and/or vitamin d2
AU2013281217B2 (en) * 2012-06-29 2017-03-02 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
CN106489971A (zh) * 2015-09-07 2017-03-15 江苏龙灯化学有限公司 一种除草组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
EP0619306B1 (en) * 1993-04-05 1996-09-11 Wisconsin Alumni Research Foundation 19-Nor-vitamin D3 compounds with substituent at 2-position
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
NZ522909A (en) * 2000-05-31 2004-09-24 Wisconsin Alumni Res Found 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
US20030195175A1 (en) * 2002-03-25 2003-10-16 Deluca Hector F. Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone

Also Published As

Publication number Publication date
KR20060040744A (ko) 2006-05-10
ZA200601721B (en) 2007-07-25
NO20061704L (no) 2006-06-19
AU2004273659A1 (en) 2005-03-31
EP1667688A1 (en) 2006-06-14
NZ545632A (en) 2009-09-25
WO2005027914A1 (en) 2005-03-31
RU2006107649A (ru) 2007-11-10
JP2007505882A (ja) 2007-03-15
RU2326674C2 (ru) 2008-06-20
CA2538993A1 (en) 2005-03-31
IL174043A0 (en) 2006-08-01
TW200512183A (en) 2005-04-01
MXPA06002947A (es) 2006-05-31
US20050065129A1 (en) 2005-03-24
CN1852718A (zh) 2006-10-25

Similar Documents

Publication Publication Date Title
BRPI0408784A (pt) método para usar um composto
BR0314308A (pt) Composto, composição farmacêutica, métodos para bloquear uma combinação de mu, kappa, delta ou receptor (heterodìmero) dos mesmos em mamìferos, para tratar ou prevenir obesidade e doenças relacionadas, para suprimir o apetite em um paciente em necessidade deste, e para realizar a perda de peso em um paciente obeso, e, uso de um composto
SI2527315T1 (sl) Spojine, sestavki in metode za zdravljenje amiloidnih bolezni in sinukleinopatij, kot so Alzheimerjeva bolezen, diabetes tipa 2 in Parkinsonova bolezen
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l&#39;obesite
WO2005089502A3 (en) Methods for the treatment of synucleinopathies
BRPI0410170A (pt) preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade
NO20054714L (no) Fremgangsmate for behandling av svake kognitive svekkelser, og for a forhindre eller utsette Alzheimers sykdom
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
UY26130A1 (es) Compuestos para tratar la obesidad
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
BR0213540A (pt) Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos
TW200719882A (en) Treatment of connective tissue diseases of the skin
BRPI0417376A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
WO2004012762A3 (en) Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
FR2712811B1 (fr) Procédé pour lutter contre l&#39;adiposite et compositions utilisables à cet effet.
SE0400184D0 (sv) New therapeutical use
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.